- 5 mg Loteprednol etabonate;
- 0.01% w/v Benzalkonium chloride NF;
- Sterile aqueous vehicle.
Loteflam eye drops are indicated for the treatment of:
- Cornea and anterior segment of the globe such as:
-- Selected infective conjunctivitides;
-- Punctate keratitis;
-- Herpes zoster keratitis;
-- Allergic conjunctivitis;
-- Acne rosacea;
- Bulbar conjunctiva and steroid responsive inflammatory conditions of the palpebral,
when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.
Loteflam eye drops are indicated for the treatment of post-operative inflammation following ocular surgery.
Loteflam eye drops as with other ophthalmic corticosteroids are contraindicated in most viral diseases of:
- Conjunctiva including epithelial herpes simplex keratitis;
- Fungal diseases of ocular structures;
- In mycobacterial infection of the eye;
- The cornea;
Loteflam eye drops are contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of
this medicine and to other corticosteroids.
Steroid Responsive Disease Treatment: Apply one to two drops of Loteprednol etabonate into the conjunctival sac of the
affected eye(s) 4 times daily. During the initial treatment within the first week, the dosing may be increased, up to one drop
every hour, if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve
after 2 days, the patient should be re-evaluated.
Post-Operative Inflammation: Apply one to two drops of Loteprednol etabonate into the conjunctival sac of the operated eye(s)
4 times daily beginning 24 hours after surgery and continuing throughout the first two weeks of the post-operative period.
- 5 ml Vial.